| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Aug 2025 | 1 Aug 2025 |
| Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve 1. Unaudited Financial Results For The Quarter Ended On 30Th June 2025 and other related matters thereto. 2. Increasing the Authorised Share Capital and consequential amendment to Memorandum of Association subject to approval of shareholders. 3. Formulation and approval of Employee Stock Option Scheme in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations 2021 subject to approval of shareholders. 4. Any other business / agenda. Outcome of Board Meeting held today i.e., 06th August 2025 Results for the quarter ended 30th June 2025 (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 20 May 2025 | 13 May 2025 |
| Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve 1. Audited Financial Statements and Results for the quarter and year ended 31st March 2025 for the F.Y. 2024-25 and other related matters thereto. 2. Recommendation of Final Dividend if any; for the F.Y. 2024-25 subject to approval of the same by the members in the ensuing Annual General Meeting. 3. Any other business /agenda. Outcome of the Board Meeting held on 20th May 2025: 1. Audited Standalone & Consolidated Financial Statements & Results for the Quarter and Year Ended 31st March 2025. 2. Recommendation of Final Dividend for F.Y. 2024-25 at the rate of 10% (Re. 1/- per share) on the Equity share of Rs. 10/- each subject to the approval of shareholders in the ensuing Annual General Meeting. (As per BSE Announcement Dated on 20/05/2025) | ||
| Board Meeting | 11 Feb 2025 | 4 Feb 2025 |
| Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve 1. Unaudited Financial Results for the third quarter and nine months ended 31st December 2024 of FY 2024-25 and other related matters thereto. 2. To consider any other business /agenda. Unaudited Financial Results for the third quarter and nine months ended 31st December 2024 for FY 2024-25 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company, Naresh & Co., Chartered Accountants. (As Per BSE Announcement Dated on 11/02/2025) | ||
| Board Meeting | 11 Nov 2024 | 29 Oct 2024 |
| Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve 1. Unaudited Financial Results for the quarter and half year ended 30th September 2024 for FY 2024-25 and other related matters thereto. 2. To consider any other business /agenda. Unaudited Financial Results for the quarter and half year ended 30th September 2024 (As Per BSE Announcement Dated on: 11/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.